Regeneron Pharmaceuticals Inc (REGN) Common Stock USD0.001
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
- Add to watchlist
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-down-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Annual & interim reports are not available for this stock.
Financial results for the last 5 years
Values are quoted in the stock's local currency: US dollar.
Income Statement: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
---|---|---|---|---|---|
$ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | |
Revenue: | 13,117.20 | 12,172.90 | 16,071.70 | 8,497.10 | 6,557.60 |
Operating Profit / (Loss): | 4,047.10 | 4,738.90 | 8,946.80 | 3,576.60 | 2,209.80 |
Net Interest: | n/a | n/a | n/a | n/a | n/a |
Profit Before Tax: | 4,199.30 | 4,858.80 | 9,325.80 | 3,810.40 | 2,429.10 |
Profit after tax from continuing operations: | 3,953.60 | 4,338.40 | 8,075.30 | 3,513.20 | 2,115.80 |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | n/a | n/a | n/a | n/a | n/a |
Attributable to: | |||||
Equity holders of parent company: | n/a | n/a | n/a | n/a | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | 3,705.00¢ | 4,051.00¢ | 7,640.00¢ | 3,265.00¢ | 1,938.00¢ |
Diluted: | n/a | n/a | n/a | n/a | n/a |
Adjusted: | 3,705.00¢ | 4,051.00¢ | 7,640.00¢ | 3,265.00¢ | 1,938.00¢ |
Dividend per Share: | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Balance Sheet: | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
$ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | $ (Millions) | |
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | 4,146.40 | 3,763.00 | 3,482.20 | 3,221.60 | 2,890.40 |
Intangible Assets: | 1,038.60 | 915.50 | 6.70 | n/a | n/a |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | n/a | n/a | n/a | n/a | n/a |
Other Financial Assets: | 0.00 | n/a | 0.00 | n/a | n/a |
Other Non-Current Assets: | 8,416.00 | 8,651.90 | 7,931.00 | 4,162.60 | 4,225.70 |
13,601.00 | 13,330.40 | 11,419.90 | 7,384.20 | 7,116.10 | |
Current Assets: | |||||
Inventories: | 2,580.50 | 2,401.90 | 1,951.30 | 1,916.60 | 1,415.50 |
Trade and Other Receivables: | n/a | n/a | n/a | n/a | n/a |
Cash at Bank & In Hand: | 2,730.00 | 3,105.90 | 2,885.60 | 2,193.70 | 1,617.80 |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | 14,168.70 | 10,376.30 | 9,178.00 | 5,668.80 | 4,655.80 |
19,479.20 | 15,884.10 | 14,014.90 | 9,779.10 | 7,689.10 | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | 33,080.20 | 29,214.50 | 25,434.80 | 17,163.30 | 14,805.20 |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | n/a | n/a | 719.70 | n/a | n/a |
Other Current Liabilities: | 3,423.40 | 3,141.30 | 3,212.80 | 3,442.30 | 2,096.60 |
3,423.40 | 3,141.30 | 3,932.50 | 3,442.30 | 2,096.60 | |
Net Current Assets: | c 16,055.80 | c 12,742.80 | c 10,082.40 | c 6,336.80 | c 5,592.50 |
Non-Current Liabilities: | |||||
Borrowings: | 2,702.90 | 2,701.40 | 1,980.00 | 2,695.70 | 713.90 |
Provisions: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Liabilities: | 980.80 | 707.80 | 753.50 | n/a | 905.00 |
3,683.70 | 3,409.20 | 2,733.50 | 2,695.70 | 1,618.90 | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | 7,107.10 | 6,550.50 | 6,666.00 | 6,138.00 | 3,715.50 |
Net Assets: | 25,973.10 | 22,664.00 | 18,768.80 | 11,025.30 | 11,089.70 |
Capital & reserves: | |||||
Share Capital: | n/a | n/a | n/a | n/a | n/a |
Share Premium Account: | n/a | n/a | n/a | n/a | n/a |
Other Reserves: | n/a | n/a | n/a | n/a | n/a |
Retained Earnings: | n/a | n/a | n/a | n/a | n/a |
Shareholders Funds: | 25,973.10 | 22,664.00 | 18,768.80 | 11,025.30 | 11,089.70 |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | 25,973.10 | 22,664.00 | 18,768.80 | 11,025.30 | 11,089.70 |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.